Richard H Redding

CIK 1282837 · View on SEC EDGAR ↗

Insider

First SEC filing: March 5, 2004 · Latest: March 5, 2004

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 45 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

45 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 17, 2007 CME S 10b5-1 1,250 $699.61 $874,512 7,165 Direct -14.85% Disposed 92.3% (price as of 2026-08-20)
Sept. 17, 2007 CME S 10b5-1 10 $540.35 $5,404 7,165 Direct -0.14% Disposed 149.0% (price as of 2026-08-20)
Sept. 17, 2007 CME S 10b5-1 1,240 $540.35 $670,034 7,165 Direct -14.75% Disposed 149.0% (price as of 2026-08-20)
Sept. 17, 2007 CME S 10b5-1 10 $540.35 $5,404 7,165 Direct -0.14% Disposed 149.0% (price as of 2026-08-20)
Sept. 17, 2007 CME S 10b5-1 1,240 $540.35 $670,034 7,165 Direct -14.75% Disposed 149.0% (price as of 2026-08-20)
June 15, 2007 CME S 10b5-1 1,250 $551.27 $689,088 6,945 Direct -15.25% Disposed 144.1% (price as of 2026-08-20)
March 15, 2007 CME S 10b5-1 750 $543.03 $407,272 6,945 Direct -9.75% Disposed 147.8% (price as of 2026-08-20)
March 15, 2007 CME S 10b5-1 500 $543.03 $271,515 6,945 Direct -6.72% Disposed 147.8% (price as of 2026-08-20)
April 3, 2006 CME S 10b5-1 2,050 $447.50 $917,375 6,700 Direct -23.43% Disposed 200.7% (price as of 2026-08-20)
April 3, 2006 CME S 10b5-1 450 $447.50 $201,375 6,700 Direct -6.29% Disposed 200.7% (price as of 2026-08-20)
Jan. 3, 2006 CME S 10b5-1 2,500 $368.75 $921,875 6,700 Direct -27.17% Disposed 264.9% (price as of 2026-08-20)
Oct. 3, 2005 CME S 10b5-1 1,000 $339.10 $339,100 6,700 Direct -12.99% Disposed 296.8% (price as of 2026-08-20)
July 1, 2005 CME S 10b5-1 1,000 $298.50 $298,500 6,700 Direct -12.99% Disposed 350.8% (price as of 2026-08-20)
May 4, 2005 CME S 10b5-1 250 $200.00 $50,000 6,300 Direct -3.82% Disposed 572.8% (price as of 2026-08-20)
April 1, 2005 CME S 10b5-1 750 $193.11 $144,832 6,300 Direct -10.64% Disposed 596.8% (price as of 2026-08-20)
Jan. 3, 2005 CME S 10b5-1 3,000 $229.00 $687,000 6,300 Direct -32.26% Disposed 487.6% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Sept. 15, 2009 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,340) $284.34 Sept. 15, 2019 1,340 Acquired
June 16, 2008 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,625) $419.41 June 16, 2018 1,625 Acquired
Dec. 17, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,250) $127.00 June 14, 2014 1,250 Disposed
Sept. 17, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (10) $127.00 June 14, 2014 10 Disposed
Sept. 17, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,240) $63.01 June 6, 2013 1,240 Disposed
Sept. 17, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (10) $127.00 June 14, 2014 10 Disposed
Sept. 17, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,240) $63.01 June 6, 2013 1,240 Disposed
June 15, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,480) $552.70 June 15, 2017 1,480 Acquired
June 15, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,250) $63.01 June 6, 2013 1,250 Disposed
March 15, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (750) $63.01 June 6, 2013 750 Disposed
March 15, 2007 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (500) $22.00 May 7, 2011 500 Disposed
June 15, 2006 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (1,630) $440.65 June 15, 2016 1,630 Acquired
April 3, 2006 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (450) $22.00 July 20, 2011 450 Disposed
April 3, 2006 CME Non-Qualified Stock Option (right to buy) Common Stock Class A (2,050) $22.00 May 7, 2011 2,050 Disposed
Jan. 3, 2006 CME Stock Options (Right to buy) Common Stock Class A (2,500) $22.00 July 20, 2011 2,500 Disposed
Oct. 3, 2005 CME Stock Options (Right to buy) Common Stock Class A (1,000) $22.00 July 20, 2011 1,000 Disposed
July 1, 2005 CME Stock Options (Right to buy) Common Stock Class A (1,000) $22.00 July 20, 2011 1,000 Disposed
June 15, 2005 CME Stock Options (Right to buy) Common Stock Class A (2,500) $251.95 June 15, 2015 2,500 Acquired
May 4, 2005 CME Stock Options (Right to buy) Common Stock Class A (250) $22.00 July 20, 2011 250 Disposed
April 1, 2005 CME Stock Options (Right to buy) Common Stock Class A (750) $22.00 July 20, 2011 750 Disposed
Jan. 3, 2005 CME Stock Options (Right to buy) Common Stock Class A (3,000) $22.00 July 20, 2011 3,000 Disposed
June 14, 2004 CME Stock Options (Right to buy) Common Stock Class A (4,400) $127.00 June 14, 2014 4,400 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 5, 2004 CME Class A Common Stock — Direct
March 5, 2004 CME Employee Stock Option (right to buy)→ Class A Common Stock (2,550) 2,550 Direct
March 5, 2004 CME Employee Stock Option (right to buy)→ Class A Common Stock (8,950) 8,950 Direct
March 5, 2004 CME Employee Stock Option (right to buy)→ Class A Common Stock (5,400) 5,400 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CME

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2005 $299,038 $420,000 — — — — $76,072 —

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.